- Home
- KPRX vs LDWY Comparison
KPRX vs LDWY Comparison
Compare KPRX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPRX | LDWY |
|---|---|---|
| Founded | 1998 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 6.4M |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | KPRX | LDWY |
|---|---|---|
| Price | $2.14 | $3.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 37.4K | ★ 51.7K |
| Earning Date | 11-07-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | N/A | ★ $69,769,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.80 |
| Revenue Growth | N/A | ★ 121.91 |
| 52 Week Low | $1.77 | $3.11 |
| 52 Week High | $4.18 | $6.19 |
Technical Indicators
Market Signals| Indicator | KPRX | LDWY |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 45.81 |
| Support Level | $2.03 | $3.20 |
| Resistance Level | $2.23 | $3.45 |
| Average True Range (ATR) | 0.11 | 0.30 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 80.56 | 24.41 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in industries: Specialty Ag, consisting of the Bloomia business.